C19H38N6O11
Neat
526.54
Nebramycin IV; Nebramycin factor 4; 6''-O-Carbamoylkanamycin B; 51736-76-6; 102N2046WY; RefChem:1073523; Nebramycin-4; 6"-O-carbamoylkanamycin B; orb3023107; UNII-102N2046WY; CHEBI:177756; HY-N14485; D-Streptamine, O-3-amino-6-O-(aminocarbonyl)-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2, 6-diamino-2, 6-dideoxy-alpha-D-glucopyranosyl-(1-4))-2-deoxy-; C18000; Q27896134; [(2R, 3S, 4S, 5R, 6S)-4-amino-6-[(1S, 2S, 3R, 4S, 6R)-4, 6-diamino-3-[(2R, 3R, 4R, 5S, 6R)-3-amino-6-(aminomethyl)-4, 5-dihydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-3, 5-dihydroxyoxan-2-yl]methyl carbamate; D-STREPTAMINE, O-3-AMINO-6-O-(AMINOCARBONYL)-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6)-O-(2, 6-DIAMINO-2, 6-DIDEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4))-2-DEOXY-; O-3-AMINO-6-O-(AMINOCARBONYL)-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6)-O-(2, 6-DIAMINO-2 and 6-DIDEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4))-2-DEOXY-D-STREPTAMINE
[(2R, 3S, 4S, 5R, 6S)-4-amino-6-[(1S, 2S, 3R, 4S, 6R)-4, 6-diamino-3-[(2R, 3R, 4R, 5S, 6R)-3-amino-6-(aminomethyl)-4, 5-dihydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-3 and 5-dihydroxyoxan-2-yl]methyl carbamate
InChI=1S/C19H38N6O11/c20-2-6-11(27)12(28)9(24)17(33-6)35-15-4(21)1-5(22)16(14(15)30)36-18-13(29)8(23)10(26)7(34-18)3-32-19(25)31/h4-18,26-30H,1-3,20-24H2,(H2,25,31)/t4-,5+,6+,7+,8-,9+,10+,11+,12+,13+,14-,15+,16-,17+,18+/m0/s1